成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 303162-79-0 Chemical Structure| 303162-79-0
Chemical Structure| 303162-79-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 303162-79-0

,{[proInfo.pro_purity]}

TAK-715 is a p38 MAPK inhibitor for p38α with IC50 of 7.1 nM, being 28-fold selective for p38α over p38β, showing no inhibition to p38γ/δ, JNK1, ERK1, IKKβ, MEKK1 or TAK1.

Synonyms: TAK-715

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of TAK-715

CAS No. :303162-79-0
Formula : C24H21N3OS
M.W : 399.51
SMILES Code : O=C(NC1=NC=CC(C2=C(C3=CC=CC(C)=C3)N=C(CC)S2)=C1)C4=CC=CC=C4
Synonyms :
TAK-715
MDL No. :MFCD17012805
InChI Key :HEKAIDKUDLCBRU-UHFFFAOYSA-N
Pubchem ID :9952773

Safety of TAK-715

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H319
Precautionary Statements:P305+P351+P338

Related Pathways of TAK-715

DNA
MAPK
Hedgehog
TLR

Isoform Comparison

Biological Activity

Target
  • p38β

    p38β, IC50:0.20 μM

  • p38α

    p38α, IC50:7.1 nM

In Vitro:

Cell Line
Concentration Treated Time Description Reference
Human adipose stem cells (hASCs) 10 μM 12 days TAK-715 significantly suppressed lipid accumulation during the differentiation of hASCs and downregulated the phosphorylation of p38 MAPK. PMC9965126
Rat NPCs 0, 0.05, 0.1, 0.25, 0.5, 1.0, 5, 10 μM 24 and 48 hours To evaluate the cytotoxicity of TAK-715 on NPCs, the results showed that TAK-715 was not toxic to NPCs at concentrations below 1.0 μM and could slightly decrease the cellular activity of NPCs PMC10029231
3T3-L1 preadipocytes 10 μM 8 days TAK-715 significantly suppressed lipid accumulation and intracellular triglyceride content during the differentiation of 3T3-L1 preadipocytes, and downregulated the expression and phosphorylation of C/EBP-α, PPAR-γ, STAT-3, FAS, perilipin A, p38 MAPK, and its downstream effector ATF-2. PMC9965126

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description Reference
SD rats Puncture-induced intervertebral disc degeneration model Intradiscal injection 5 μl (1 μM) Single injection To evaluate the ameliorative effect of TAK-715 on intervertebral disc degeneration in vivo, the results showed that TAK-715 delayed disc degeneration by inhibiting NPC apoptosis and ECM degradation PMC10029231

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.50mL

0.50mL

0.25mL

12.52mL

2.50mL

1.25mL

25.03mL

5.01mL

2.50mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories